| Ongoing (As at 29 Nov 2022) |
No.
|
Research Title
|
Investigator
|
Status
|
| 1. |
AEGIS II – A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subject with Acute Coronary Syndrome
Download |
Dato’ Sri Dr. Haji Azhari Rosman |
Enrollment |
| 2. |
APPIRED III – Preventing Oxidative Stress Induced Ischemic Injury and Systemic Inflammation Complications During and After Invasive Cardiac Surgery with Alkaline Phosphatase
Download |
Dr. Pau Kiew Kong |
Enrollment |
| 3. |
ABILITY DIABETES – Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diebetes Mellitus Global.
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
| 4. |
COMBINE-INTERVENE – COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events.
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
| 5. |
LEADR – Lead Evaluation for Defibrillation and Reliability
Download |
Dr. Surinder Kaur Khelae |
Enrollment |
| 6. |
CTO Registry using the HYBRID CTO ALGORITHM at IJN. (Device : Crossboss & Stingray)
Download |
Datuk Dr. Shaiful Azmi Yahaya |
Enrollment |
| 7. |
FINEARTS – A multicentre, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure(NYHA II-IV) and EF ≥40%
Download |
Dr. Teoh Chee Kiang |
Enrollment |
| 8. |
DEDICATE REGISTRY – A Post Market Registry of Abluminum® Sirolimus Eluting Coronary Stent System for Percutaneous Intervention in Patients with Diabetic Mellitus
Download |
Dato’ Sri Dr. Haji Azhari Rosman |
Enrollment |
| 9. |
GSR DEFINE – Global SYMPLICITY Registry (GSR) Denervation Findings in Real World (DEFINE) is referred to as the GSR DEFINE study
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
| 10. |
FIM-IBS – A Prospective, Non-randomized, Open lable, Non-comparative, First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
Download |
Datuk Dr. Shaiful Azmi Yahaya |
Enrollment |
| 11. |
ZEUS – Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation
Download |
Dato’ Sri Dr. Haji Azhari Rosman |
Enrollment |
| 12. |
MID-Q Response
Download |
Datuk Dr. Azlan Hussin |
Enrollment |
| 13. |
NEOS-APAC – Asian Pacific post-market clinical follow-up study in patients with acute or chronic aortic dissection or aortic aneurysm treated with E-vita OPEN NEO
Download |
Mr. Paneer Selvam |
Enrollment |
| 14. |
RESTORE – A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging
Download |
Dr. Geetha A/P Kandavello @ Kandhavel |
Enrollment |
| 15. |
TOMORROW – A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children with Pulmonary Arterial Hypertension
Download |
Dr. Geetha A/P Kandavello @ Kandhavel |
Enrollment |
| 16. |
VFAHF STUDY – Ventricle from Atrium Heart Failure Clinical Study (VFAHF)
Download |
Datuk Dr. Azlan Hussin |
Enrollment |
| 17. |
SALTO – A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Event-Driven, Group-Sequential Study with Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged ≥2 to <18 years with Pulmonary Arterial Hypertension
Download |
Dr. Geetha A/P Kandavello @ Kandhavel |
Enrollment |
| 18. |
SCORE REGISTRY – Sequent® SCB ‘’All Comers’’ Post Market Clinical Follow up (PMCF)
Download |
Dato’ Dr. Amin Ariff Nuruddin |
Enrollment |
| 19. |
STRIDE – Effects of semaglutide on functional capacity in patients withtype 2 diabetes and peripheral arterial disease
Download |
Datuk Dr. Shaiful Azmi Yahaya |
Enrollment |
| 20. |
PRIME-FFR – Prognostic impact of lesion-specific hemodynamic index and disease characteristics in patients with coronary artery disease assessed by fractional flow reserve
Download |
Datuk Dr. Azlan Hussin |
Enrollment |
